Short position was at 1 million end of May. If anyone is worried I would think its that position, but as BIND is up significantly over the past 30 days I'd bet some of that was covered. I'm pretty long here, longer than most, and if AMGN didnt come through I wouldnt have a worry in the world. This is a longer term play but I would not be surprised to see BIND with a 500MM market cap eoy. Less likely would be a $100MM market cap. Lets get some data.
If the kinase inhibitor presented on slide 7 yesterday at JMP is in fact from Amgen, then is showed tumor shrinkage in the Accurin D efficacy model (post 21 days) vs. Parent API. Amgen will sign on. Stock goes to $14 - $15.